	Assessing a drug candidate’s suitability during preformulation is essential to minimize the risk of costly downstream failure. Stability is a defining feature of biotherapeutic performance; measuring formulation stability during early-phase screening allows developers to make robust predictions of suitability for further development. 	 	Read this article and other articles in 

Analytical Methods

Biopharmaceutical Analysis

Development

Drug Delivery

Formulation

Formulation and Drug Delivery, Other

BioPharm International-10-15-2015

This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.